Pharmascience Inc., a leading Canadian manufacturer of prescription, over-the-counter, and behind-the-counter generic pharmaceuticals, has selected Exasol to give end-users faster, more efficient access to data. Pharmascience will use Exasol’s high performance analytics database to boost its business intelligence (BI) to deliver better reporting and performance.
“We chose Exasol for its superior performance and the unmatched level of service their team provides. Exasol aligns with Pharmascience’s strategic plan to move on-prem infrastructure to the cloud,” said David Schleifstein, business intelligence manager at Pharmascience Inc. “The support staff at Exasol are always available to assist my team with questions and work closely with us to find solutions to any problems, including the integration process with our existing ERP system.”
With Exasol, Pharmascience Inc. will be able to generate lightning-fast results, allowing the company to gain business insights faster, easier, and more cost-effectively. In addition, Exasol will free up valuable resources, enabling the BI team to focus on development and other strategic business initiatives.
Pharmascience Inc. partnership with Exasol allows the company to achieve more flexibility to deal with structured and semi-structured data, bringing all data together in a 360-degree view for deeper insights. This paired with quick and efficient access to data, without idle refresh times, will provide Pharmascience Inc. with accurate and precise analysis necessary for business success. Additionally, Exasol’s analytics database easily integrates with BI tools, like Tableau, to help organisations visualise data to make better business decisions. Pharmascience Inc. will use Exasol in conjunction with Aecorsoft and Tableau for reporting and analytics.
